Marc Engelhardt
Direttore Tecnico/Scientifico/R&S presso BASILEA PHARMACEUTICA AG
Profilo
Marc Engelhardt is currently the Chief Medical Officer at Basilea Pharmaceutica AG since 2018.
Prior to this, he worked as the Director-Global Program Medical at Novartis Pharma AG.
Dr. Engelhardt completed his undergraduate and doctorate degrees at Johann Wolfgang Goethe-Universität Frankfurt am Main.
Posizioni attive di Marc Engelhardt
| Società | Posizione | Inizio |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
Precedenti posizioni note di Marc Engelhardt
| Società | Posizione | Fine |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formazione di Marc Engelhardt
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Aziende private | 1 |
|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Marc Engelhardt
